Assenagon Asset Management S.A. Regenxbio Inc. Transaction History
Assenagon Asset Management S.A.
- $65.1 Billion
- Q3 2025
A detailed history of Assenagon Asset Management S.A. transactions in Regenxbio Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 705,403 shares of RGNX stock, worth $8.92 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
705,403
              Previous 572,461
              
        
           23.22%
        
      
          
        Holding current value
$8.92 Million
            Previous $4.7 Million
            
        
           44.86%
        
      
          
        % of portfolio
0.01%
            Previous 0.01%
          
        Shares
	  14 transactions
	
  Others Institutions Holding RGNX
# of Institutions
183Shares Held
45.3MCall Options Held
103KPut Options Held
100K- 
    
      Black Rock Inc. New York, NY8.61MShares$109 Million0.0% of portfolio
- 
    
      Redmile Group, LLC San Francisco, CA4.78MShares$60.4 Million4.77% of portfolio
- 
    
      Jpmorgan Chase & CO New York, NY4.36MShares$55.2 Million0.0% of portfolio
- 
    
      Vanguard Group Inc Valley Forge, PA3.42MShares$43.2 Million0.0% of portfolio
- 
    
      State Street Corp Boston, MA1.84MShares$23.3 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $546M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...